Metacort

Mometasone furoate, the active ingredient in Metacort, is a corticosteroid presented as a nasal spray for nasal use. It is employed to reduce inflammation in the nasal passages of patients with allergic conditions and nasal polyps.

GNH USA supplies Metacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metacort is a topical corticosteroid that acts on inflammatory processes of the nasal mucosa.

Allergic rhinitis: alleviates nasal congestion, itching and sneezing caused by seasonal or perennial allergens. Nasal polyps: reduces polyp size and improves nasal airflow after surgical removal. Non‑allergic rhinitis: diminishes chronic nasal irritation and discharge in patients without an allergic trigger.

Mometasone nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Altered taste or bitter taste - Throat irritation - Cough

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Cataracts or glaucoma - Severe allergic reaction (anaphylaxis) - Nasal septum perforation - Opportunistic fungal infection of the nasal cavity - Systemic corticosteroid effects such as hyperglycemia

Use Metacort only under medical supervision and follow prescribed duration.

Avoid use in patients with known hypersensitivity to mometasone or any formulation component. Caution after recent nasal surgery or trauma; monitor for delayed healing. Monitor for signs of systemic corticosteroid exposure, especially with long‑term therapy. Do not exceed recommended treatment length without physician review. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Mometasone nasal spray can interact with other medicines that affect steroid metabolism or immune response.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic exposure. - Concurrent systemic corticosteroids can lead to additive glucocorticoid effects. - Live vaccines: immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin) may modestly raise levels. - Antifungal azoles (e.g., itraconazole) require monitoring for systemic effects.